Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.
The enzyme 5α-reductase, which converts testosterone to dihydrotestosterone (DHT), performs key functions in the androgen receptor (AR) signaling pathway. The three isoenzymes of 5α-reductase identified to date are encoded by different genes: SRD5A1, SRD5A2, and SRD5A3. In this study, we investigate...
Main Authors: | Jin Li, Zhiyong Ding, Zhengxin Wang, Jing-Fang Lu, Sankar N Maity, Nora M Navone, Christopher J Logothetis, Gordon B Mills, Jeri Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3237548?pdf=render |
Similar Items
-
Prioritizing genes associated with prostate cancer development
by: Troncoso Patricia, et al.
Published: (2010-11-01) -
Was DHT production by 5α-reductase friend or for in prostate cancer?
by: Takeo eKosaka, et al.
Published: (2014-09-01) -
Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01) -
The androgen-thyroid hormone crosstalk in prostate cancer and the clinical implications
by: Sepehr Torabinejad, et al.
Published: (2023-05-01) -
Correction: TCTP is an androgen-regulated gene implicated in prostate cancer.
by: Mari Kaarbø, et al.
Published: (2015-01-01)